Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 621,500 | 168,000 | 112,400 | 179,300 | 271,513 |
| Receivables | 230,900 | 270,700 | 271,100 | 146,100 | 148,474 |
| Inventories | 307,000 | 222,500 | 205,800 | 142,800 | 74,002 |
| TOTAL | $1,195,900 | $686,200 | $620,800 | $485,400 | $510,218 |
| Non-Current Assets | |||||
| PPE Net | 644,100 | 542,300 | 510,200 | 407,200 | 376,448 |
| Intangibles | 929,800 | 979,500 | 1,021,300 | 168,700 | 74,866 |
| Other Non-Current Assets | 113,400 | 119,300 | 77,100 | 8,900 | 8,579 |
| TOTAL | $1,687,300 | $1,641,100 | $1,608,600 | $584,800 | $459,893 |
| Total Assets | $2,883,200 | $2,327,300 | $2,229,400 | $1,070,200 | $970,111 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 12,900 | 10,100 | N/A | N/A |
| Accounts payable and accrued liabilities | 136,100 | 94,800 | 80,700 | 41,800 | 34,649 |
| Accrued Expenses | 131,500 | 101,900 | 88,900 | 42,700 | 40,905 |
| Other current liabilities | 116,900 | 6,700 | 20,700 | 2,400 | 3,266 |
| TOTAL | $384,500 | $216,300 | $200,400 | $100,100 | $105,856 |
| Non-Current Liabilities | |||||
| Long Term Debt | 841,000 | 798,400 | 784,500 | 13,500 | 248,094 |
| Deferred Revenues | N/A | N/A | N/A | 13,200 | 7,036 |
| Other Non-Current Liabilities | 157,500 | 74,600 | 103,600 | 27,000 | 11,523 |
| TOTAL | $1,051,700 | $1,022,500 | $1,018,100 | $57,800 | $268,050 |
| Total Liabilities | $1,436,200 | $1,238,800 | $1,218,500 | $157,900 | $373,906 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,300 | 52,000 | 51,200 | 49,495 | 40,688 |
| Common Shares | 100 | 100 | 100 | 100 | 41 |
| Retained earnings | 726,900 | 421,800 | 367,300 | 337,100 | 254,480 |
| Other shareholders' equity | -24,900 | -9,500 | -5,100 | -3,200 | -4,751 |
| TOTAL | $1,447,000 | $1,088,500 | $1,010,900 | $912,300 | $596,205 |
| Total Liabilities And Equity | $2,883,200 | $2,327,300 | $2,229,400 | $1,070,200 | $970,111 |